News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2012

19 December, 2012 PledPharma Broadens Patient Base for the PLIANT Study News English IR Optional
26 October, 2012 PledPharma AB (publ) Interim report January-September 2012 News English Report Interim Q3 IR Optional
24 August, 2012 PledPharma AB (publ) Interim report January – June 2012 News English Report Interim Q2 IR Optional
1 August, 2012 PledPharma PledOx® clinical trial application approved News English IR Optional
6 July, 2012 PledPharma’s PledOx® safety studies positive News English IR Optional
27 April, 2012 Interim report January-March 2012 News English Report Interim Q1 IR Optional
3 April, 2012 PledPharma receives 500,000 SEK in VINNOVA financing News English IR Optional
17 February, 2012 PledPharma AB (publ) Full year report January – December 2011 News English Report Interim Yearend IR Optional

Calendar and upcoming reports

May 3, 2024
Interim Report Q1 2024 (7:00am CEST)

May 6, 2024
Annual General Meeting

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com